Giuditta Adorni

Parma, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Ixekizumab Treatment Persistence in Psoriatic Arthritis: Response to Joaquin et al.

Ixekizumab Treatment Persistence in Psoriatic Arthritis: Response to Joaquin et al.

Journal: Journal of psoriasis and psoriatic arthritis

Published: February 26, 2026

Comparative treatment persistence of upadacitinib vs. tofacitinib in psoriatic arthritis: a multicenter observational study from the BIRRA cohort.

Comparative treatment persistence of upadacitinib vs. tofacitinib in psoriatic arthritis: a multicenter observational study from the BIRRA cohort.

Journal: Frontiers in medicine

Published: February 18, 2026

Does Prior Exposure Affect Retention? A Real-World, Multicentre Assessment of IL-17 Inhibitor Cycling in Psoriatic Arthritis.

Does Prior Exposure Affect Retention? A Real-World, Multicentre Assessment of IL-17 Inhibitor Cycling in Psoriatic Arthritis.

Journal: Rheumatology and therapy

Published: December 22, 2025

Six months predictors of DAPSA Remission With Guselkumab in Psoriatic Arthritis in a Multicenter Real-World Study.

Six months predictors of DAPSA Remission With Guselkumab in Psoriatic Arthritis in a Multicenter Real-World Study.

Journal: Scientific reports

Published: December 14, 2025

Drug retention of TNF versus IL-23 inhibitors in psoriatic arthritis: a multicenter real-life cohort study.

Drug retention of TNF versus IL-23 inhibitors in psoriatic arthritis: a multicenter real-life cohort study.

Journal: Therapeutic advances in musculoskeletal disease

Published: June 23, 2025

Filgotinib Effectiveness in Rheumatoid Arthritis: Observational Analysis of a Large Multicenter Cohort.

Filgotinib Effectiveness in Rheumatoid Arthritis: Observational Analysis of a Large Multicenter Cohort.

Journal: Rheumatology and therapy

Published: June 20, 2025

Guselkumab effectiveness in real-world settings: observations from an Italian multicentre study.

Guselkumab effectiveness in real-world settings: observations from an Italian multicentre study.

Journal: Rheumatology advances in practice

Published: April 27, 2025

Validation of the Italian version of the sarcopeniaspecific quality of life questionnaire (SarQoL®).

Validation of the Italian version of the sarcopeniaspecific quality of life questionnaire (SarQoL®).

Journal: Journal of bodywork and movement therapies

Published: April 07, 2025

Ixekizumab Retention Rate and Predictors of Treatment Persistence in Psoriatic Arthritis: Results of an Italian Multicenter Study.

Ixekizumab Retention Rate and Predictors of Treatment Persistence in Psoriatic Arthritis: Results of an Italian Multicenter Study.

Journal: Journal of psoriasis and psoriatic arthritis

Published: January 07, 2025

Multicenter observational study on the efficacy of selective Janus Kinase-1 inhibitor upatacitinib in rheumatoid arthritis.

Multicenter observational study on the efficacy of selective Janus Kinase-1 inhibitor upatacitinib in rheumatoid arthritis.

Journal: Minerva medica

Published: October 08, 2024

Effectiveness and Predictors of Long-Term Treatment Response to Tofacitinib in Rheumatoid Arthritis Cohort: General Analysis and Focus on High-Cardiovascular-Risk Subgroup-A Multicenter Study.

Effectiveness and Predictors of Long-Term Treatment Response to Tofacitinib in Rheumatoid Arthritis Cohort: General Analysis and Focus on High-Cardiovascular-Risk Subgroup-A Multicenter Study.

Journal: Medicina (Kaunas, Lithuania)

Published: September 28, 2024

Influence of Safety Warnings on the Prescribing Attitude of JAK Inhibitors for Rheumatoid Arthritis in Italy.

Influence of Safety Warnings on the Prescribing Attitude of JAK Inhibitors for Rheumatoid Arthritis in Italy.

Journal: Journal of clinical medicine

Published: June 09, 2024

Showing 1-12 of 16

Last Updated: 09/26/2026